IMOCOBEL
IMOCOBEL and the 18 companies it controls according to the LEI register and the annual accounts: the structure, the figures, each company's health and where the risk sits.
Sum of the filed annual accounts of 18 of the 19 Belgian companies (financial years 2024-2025). Not a consolidation: receivables, participations and sales between group companies are not eliminated, so they count.
Group risk
How healthy the group's Belgian companies are, and where the risk sits. A weak subsidiary can cost the parent money, and the other way round.
- The parent itself: IMOCOBEL, healthy (96/100).
- 9 companies with negative equity: PROPINTRA (-€975,840), IMOCOBEL VENTURES (-€745,035), Capnor Co-Investments II (-€641,638), PROPINVEST (-€619,503), Medi-Immobilier (-€200,093), Capnor Co-Investments I (-€133,920) and 3 more.
- 10 companies with a loss in the latest year: PROPINTRA (-€1.3m), IMOCOBEL VENTURES (-€1.0m), Capnor Co-Investments II (-€328,980), PROPINVEST (-€301,536), Capnor Co-Investments I (-€108,508), Capnor Co-Investments III (-€106,862) and 4 more.
- 1 company no longer active in the register: VAN RUYS PRINTING.
- 45.7% of the added-up total assets sits in one company: IMOCOBEL.
- 0.3% of the added-up total assets sits at companies with an elevated or high risk.
Group structure
Who consolidates whom according to the LEI register, completed with who holds more than half of the shares according to the annual accounts. Both mean control.
- IMOCOBEL12 subsidiariesHealthy · 96€383.3m €274.3m 2025
- No verdict€3.1m -€133,920 2024
- No verdict€2.4m -€101,862 2024
- No verdict€1.5m -€32,425 2024
- No verdict€3.9m -€7,396 2024
- No verdict€2,395 €2,368 2024
- CYJELO1 subsidiaryHealthy · 93€1.6m €361,316 2025
- Fair · 55€1.3m -€200,093 2025
- IMOCOBEL VENTURES1 subsidiaryNo verdict€20.8m -€745,035 2024
- No verdict€15.1m -€641,638 2025
- Fair · 55€161.3m €122.9m 2024
- Healthy · 84€23.6m €2.2m 2025
- PROPINTRA1 subsidiaryFair · 53€8.2m -€975,840 2025
- PROPINVEST1 subsidiaryFair · 53€5.6m -€619,503 2025
- Healthy · 95€3.3m €1.0m 2025
- Healthy · 90€199.3m €198.8m 2025
High risk Elevated Healthy Fair No verdict Amounts: total assets and equity from the latest accounts.
Events in the group
Bankruptcies, director changes, capital changes and other publications of all Belgian group companies, over the last two years.
-
2 directors appointed, 1 director resigning
What is my exposure to this group?
The companies of this group you keep in your lists or follow, seen together.
Sign in to see which customers or suppliers from your lists belong to this group, and how they stand.
Where do these figures come from?
Completed with the annual accounts: a company of which another Belgian company holds more than half of the shares, by the list of holdings or the shareholder structure in its accounts, stands under that company, with the share. The register of ultimate beneficial owners (UBO) is not public.
The group's make-up comes from the LEI register (GLEIF): which company consolidates which other, directly or ultimately. A company whose link the register does not state is not listed here, even if it does belong to the group.
The amounts are those of the annual accounts each Belgian company filed with the National Bank, added up without consolidation. The verdict per company is that of its dossier on Checked.be. Everything is updated every night.
Updated on 10-10-2026